NDC 0078-0904

SIMBRINZA

Brinzolamide/brimonidine Tartrate

SIMBRINZA is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Brinzolamide; Brimonidine Tartrate.

• Product ID: 0078-0904_9524ff62-7850-405a-9b93-311e8dde17ea
• NDC: 0078-0904
• Product Type: Human Prescription Drug
• Proprietary Name: SIMBRINZA
• Generic Name: Brinzolamide/brimonidine Tartrate
• Dosage Form: Suspension/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2013-05-01
• Marketing Category: NDA / NDA
• Application Number: NDA204251
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: BRINZOLAMIDE; BRIMONIDINE TARTRATE
• Active Ingredient Strength: 10 mg/mL; mg/mL
• Pharm Classes: Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0078-0904-38

1 BOTTLE in 1 CARTON (0078-0904-38) > 8 mL in 1 BOTTLE

• Marketing Start Date: 2020-08-04
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "SIMBRINZA" or generic name "Brinzolamide/brimonidine Tartrate"

NDC	Brand Name	Generic Name
0065-4147	SIMBRINZA	brinzolamide/brimonidine tartrate
0078-0904	SIMBRINZA	brinzolamide/brimonidine tartrate